(2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol

C42H70O13 — CID 46211015

IUPAC(2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol
SMILESC[C@@H]1O[C@@H](OC(C)(C)/C=C/C[C@](C)(O)[C@H]2CC[C@@]3(C)[C@@H]4CC=C5[C@@H](CC[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C5(C)C)[C@]4(C)[C@@H](O)C[C@]23C)[C@H](O)[C@H](O)[C@H]1O
InChIInChI=1S/C42H70O13/c1-21-29(45)31(47)34(50)36(52-21)55-37(2,3)16-10-17-41(8,51)25-15-18-39(6)26-13-11-22-23(42(26,9)27(44)19-40(25,39)7)12-14-28(38(22,4)5)54-35-33(49)32(48)30(46)24(20-43)53-35/h10-11,16,21,23-36,43-51H,12-15,17-20H2,1-9H3/b16-10+/t21-,23+,24+,25-,26-,27-,28-,29-,30+,31+,32-,33+,34+,35-,36-,39-,40+,41-,42-/m0/s1
InChIKeyYPMVCQPCLRLUQR-OEGUSSEYSA-N
MW783.01 g/mol
LogP2.07
Rot. Bonds9

About (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol

(2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol (PubChem CID 46211015) has the molecular formula C42H70O13 and a molecular weight of 783.01 g/mol. Its IUPAC name is (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol.

Molecular Properties

Compound Name(2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol
PubChem CID46211015
Molecular FormulaC42H70O13
Molecular Weight783.01 g/mol
Exact Mass782.48
IUPAC Name(2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol
SMILESC[C@@H]1O[C@@H](OC(C)(C)/C=C/C[C@](C)(O)[C@H]2CC[C@@]3(C)[C@@H]4CC=C5[C@@H](CC[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C5(C)C)[C@]4(C)[C@@H](O)C[C@]23C)[C@H](O)[C@H](O)[C@H]1O
InChIInChI=1S/C42H70O13/c1-21-29(45)31(47)34(50)36(52-21)55-37(2,3)16-10-17-41(8,51)25-15-18-39(6)26-13-11-22-23(42(26,9)27(44)19-40(25,39)7)12-14-28(38(22,4)5)54-35-33(49)32(48)30(46)24(20-43)53-35/h10-11,16,21,23-36,43-51H,12-15,17-20H2,1-9H3/b16-10+/t21-,23+,24+,25-,26-,27-,28-,29-,30+,31+,32-,33+,34+,35-,36-,39-,40+,41-,42-/m0/s1
InChIKeyYPMVCQPCLRLUQR-OEGUSSEYSA-N
XLogP2.07
TPSA218.99 Ų
H-Bond Donors9
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms55
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500783.01
LogP ≤ 52.07
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol?
The IUPAC name of (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol (CID 46211015) is (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol.
What is the SMILES notation for (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol?
The canonical SMILES for (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol is C[C@@H]1O[C@@H](OC(C)(C)/C=C/C[C@](C)(O)[C@H]2CC[C@@]3(C)[C@@H]4CC=C5[C@@H](CC[C@H](O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C5(C)C)[C@]4(C)[C@@H](O)C[C@]23C)[C@H](O)[C@H](O)[C@H]1O.
What is the InChIKey of (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol?
The InChIKey is YPMVCQPCLRLUQR-OEGUSSEYSA-N. The full InChI is InChI=1S/C42H70O13/c1-21-29(45)31(47)34(50)36(52-21)55-37(2,3)16-10-17-41(8,51)25-15-18-39(6)26-13-11-22-23(42(26,9)27(44)19-40(25,39)7)12-14-28(38(22,4)5)54-35-33(49)32(48)30(46)24(20-43)53-35/h10-11,16,21,23-36,43-51H,12-15,17-20H2,1-9H3/b16-10+/t21-,23+,24+,25-,26-,27-,28-,29-,30+,31+,32-,33+,34+,35-,36-,39-,40+,41-,42-/m0/s1.
What are the key properties of (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol?
(2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol has a molecular weight of 783.01 g/mol, XLogP of 2.07, 9 rotatable bonds, 9 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3R,4R,5R,6S)-2-[(E,6S)-6-hydroxy-6-[(3S,8S,9R,10R,11S,13R,14S,17S)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-3-en-2-yl]oxy-6-methyloxane-3,4,5-triol is sourced from PubChem (CID 46211015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).